AUD5.31
0.76% today
Australia, Sep 15, 08:10 am CET
ISIN
AU0000013559
Symbol
ALX

Atlas Arteria Target price 2025 - Analyst rating & recommendation

Atlas Arteria Classifications & Recommendation:

Buy
13%
Hold
47%
Sell
40%

Atlas Arteria Price Target

Target Price AUD5.36
Price AUD5.31
Potential
Number of Estimates 10
10 Analysts have issued a price target Atlas Arteria 2026 . The average Atlas Arteria target price is AUD5.36. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 15 analysts: 2 Analysts recommend Atlas Arteria to buy, 7 to hold and 6 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Atlas Arteria stock has an average upside potential 2026 of . Most analysts recommend the Atlas Arteria stock at Hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Million AUD 145.90 161.77
8.88% 10.88%
EBITDA Margin 43.39% 51.31%
9.30% 18.26%
Net Margin 188.69% 199.15%
1.35% 5.54%

10 Analysts have issued a sales forecast Atlas Arteria 2025 . The average Atlas Arteria sales estimate is

AUD162m
Unlock
. This is
10.88% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
AUD178m 21.78%
Unlock
, the lowest is
AUD142m 2.87%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 AUD146m 8.88%
2025
AUD162m 10.88%
Unlock
2026
AUD171m 5.47%
Unlock
2027
AUD178m 4.27%
Unlock

10 Analysts have issued an Atlas Arteria EBITDA forecast 2025. The average Atlas Arteria EBITDA estimate is

AUD83.0m
Unlock
. This is
31.12% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
AUD117m 84.12%
Unlock
, the lowest is
AUD63.3m 0.03%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 AUD63.3m 1.25%
2025
AUD83.0m 31.12%
Unlock
2026
AUD89.3m 7.63%
Unlock
2027
AUD94.0m 5.20%
Unlock
2028
AUD74.7m 20.50%
Unlock

EBITDA Margin

2024 43.39% 9.30%
2025
51.31% 18.26%
Unlock
2026
52.35% 2.03%
Unlock
2027
52.82% 0.90%
Unlock

10 Atlas Arteria Analysts have issued a net profit forecast 2025. The average Atlas Arteria net profit estimate is

AUD322m
Unlock
. This is
17.03% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
AUD579m 110.27%
Unlock
, the lowest is
AUD156m 43.19%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 AUD275m 7.41%
2025
AUD322m 17.03%
Unlock
2026
AUD416m 29.11%
Unlock
2027
AUD453m 8.97%
Unlock
2028
AUD415m 8.51%
Unlock

Net Margin

2024 188.69% 1.35%
2025
199.15% 5.54%
Unlock
2026
243.79% 22.42%
Unlock
2027
254.78% 4.51%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share AUD 0.19 0.22
5.56% 15.79%
P/E 23.73
EV/Sales 56.52

10 Analysts have issued a Atlas Arteria forecast for earnings per share. The average Atlas Arteria EPS is

AUD0.22
Unlock
. This is
15.79% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
AUD0.40 110.53%
Unlock
, the lowest is
AUD0.11 42.11%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 AUD0.19 5.56%
2025
AUD0.22 15.79%
Unlock
2026
AUD0.29 31.82%
Unlock
2027
AUD0.31 6.90%
Unlock
2028
AUD0.29 6.45%
Unlock

P/E ratio

Current
2026
18.38 22.55%
Unlock
2027
16.87 8.22%
Unlock
2028
18.44 9.31%
Unlock

Based on analysts' sales estimates for 2025, the Atlas Arteria stock is valued at an EV/Sales of

56.52
Unlock
and an P/S ratio of
47.26
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 62.66 2.22%
2025
56.52 9.81%
Unlock
2026
53.58 5.19%
Unlock
2027
51.39 4.10%
Unlock

P/S ratio

Current 52.40 2.65%
2025
47.26 9.81%
Unlock
2026
44.81 5.19%
Unlock
2027
42.98 4.10%
Unlock

Current Atlas Arteria Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JEFFERIES
Locked
Locked
Locked Apr 22 2025
E&P
Locked
Locked
Locked Feb 26 2025
JEFFERIES
Locked
Locked
Locked Feb 26 2025
Analyst Rating Date
Locked
JEFFERIES:
Locked
Locked
Apr 22 2025
Locked
E&P:
Locked
Locked
Feb 26 2025
Locked
JEFFERIES:
Locked
Locked
Feb 26 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today